-- Scott B. Ullem, Corporate Vice President, Chief Financial Officer, on April 09, 2026, sold 13,000 shares in Edwards Lifesciences (EW) for $1,040,544. Following the Form 4 filing with the SEC, Ullem has control over a total of 306,017 common shares of the company, with 39,699 shares held directly and 266,318 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1099800/000122520826004476/xslF345X05/doc4.xml